How do you counsel patients about the likelihood of improvement in kidney disease after anti-cancer treatment is initiated in a patient with malignancy associated membranous nephropathy?
Are there predictive or prognostic markers that may inform your discussions?
1 Answer
Mednet MemberInvited Expert
Nephrology · Memorial Sloan Kettering Cancer Center
Answered on
There are numerous case reports to support that if the patient has a paraneoplastic MN then the expectation is that the renal lesion will respond to cancer directed therapy.
Join for free or sign in to see the full answer